Focused VarSome alternative

A VarSome alternative for focused cardiovascular review

CardioGen AI is worth evaluating when the goal is a bounded LDLR, APOB, PCSK9, or LDLRAP1 evidence review, not a replacement for a full clinical genomics pipeline.

Neutral guide based on official product documentation reviewed 19 August 2026. Verify current vendor scope before making a clinical or procurement decision.

Start by naming what you want to replace

Teams searching for a VarSome alternative may mean four different things: a public place to look up a variant, a clinical NGS pipeline, an organization-wide interpretation workbench, or a simpler way to review one disease-focused workflow. Those are different jobs, and no honest comparison should treat them as interchangeable.

CardioGen AI addresses the last need. Its current model is limited to four genes associated with familial hypercholesterolemia workflows. It keeps the submitted evidence, binary model output, confidence, explanation, and feature contributions together, then supports a report handoff. It does not claim the breadth, medical-device status, raw-sequence processing, or production integrations documented for VarSome Clinical.

That narrower boundary can be useful when a team wants to test whether a model-assisted cardiovascular review is understandable before considering a larger implementation. It is a reason to run a focused evaluation, not evidence that CardioGen AI is clinically equivalent to VarSome Clinical.

Read the FH evidence-review map →

Worth evaluating when

You want a bounded cardiovascular review

Your test path centers on LDLR, APOB, PCSK9, or LDLRAP1.
You can use synthetic or appropriately de-identified inputs.
You want the model inputs, confidence, explanation, and contributions visible together.
You need guided single-variant review, simple batch triage, and a report artifact.
You are evaluating comprehension and handoffs, not seeking a diagnostic result.

VarSome Clinical is the better fit when

You need a broad clinical genomics pipeline

Your workflow starts from FASTQ or VCF files and spans panels, exomes, or genomes.
You need documented germline or somatic workflows across small variants, CNVs, or structural variants.
You need a current CE-IVDR Class C medical-device scope within an appropriate governed process.
You need extensive source aggregation, configurable guideline rules, or organization knowledge management.
You need established deployment, laboratory integration, or service arrangements.

Direct comparison

CardioGen AI narrows the job rather than matching the platform

This table compares documented workflow scope. It does not compare clinical performance, because no independent head-to-head validation between the products is available.

Evaluation question	VarSome Clinical	CardioGen AI
Primary job	Clinical NGS variant calling, annotation, classification, and reporting across documented germline and somatic workflows	Research-use evaluation of a guided cardiovascular variant evidence-review workflow
Current scope	Panels, exomes, and genomes, with documented support for small variants, CNVs, and structural variants	LDLR, APOB, PCSK9, and LDLRAP1 in the current classification model
Inputs	Documented FASTQ and VCF processing plus case and variant information	Guided single-variant evidence entry and de-identified CSV, VCF, or text-list batch review; no raw FASTQ calling
Interpretation view	Annotations, triggered guideline rules, germline or somatic classification, and custom classifications	Submitted inputs, binary model result, confidence, plain-language explanation, and ranked feature contributions
Team workflow	Configurable tables, reports, integrations, and organization-level classification knowledge	Account-scoped reviews, a model evidence view, simple batch triage, and a saved PDF report record
Intended-use boundary	Use the current VarSome Clinical documentation, validated configuration, and local governance to determine permitted use	Research and workflow evaluation only; not presented as a clinically validated diagnostic device

Search intent

The right alternative depends on the job

Before arranging demos, decide which part of VarSome you are trying to replace. This prevents a focused tool from being judged as a complete pipeline, or a database lookup from being mistaken for interpretation.

You need a public variant lookup

Start with the original public evidence source. ClinVar archives submitted reports about variants and their relationships to health, including review status and supporting records. A public record is evidence to inspect, not an automated clinical verdict.

You need a clinical NGS pipeline

Evaluate VarSome Clinical and other broad platforms against your assays, genome builds, variant types, validation requirements, integrations, and governance. CardioGen AI does not cover this job.

You need an organization workbench

Prioritize tools with configurable classifications, internal knowledge, role controls, review histories, reporting, and integration support. CardioGen AI currently exposes a smaller account-scoped review path and should not be treated as a mature enterprise knowledge system.

You need one focused FH evaluation

CardioGen AI is a candidate when the review stays inside four supported genes and the question is whether visible model evidence improves inspection and explanation. Use synthetic or appropriately de-identified material and keep qualified review outside the model.

A focused evaluation

One path, five observable handoffs

The goal is to learn whether the workspace makes one supported review easier to inspect and explain. The trial should test a workflow question, not merely generate a result.

01
Define the use caseName the supported gene, reviewer, evidence inputs, and non-clinical evaluation question.
02
Enter de-identified evidenceUse a synthetic or properly de-identified single variant or batch.
03
Inspect the model resultKeep the output, confidence, submitted evidence, and explanation in view.
04
Review contributionsCheck which features moved the model and where independent evidence is still required.
05
Export and critiqueUse the report to identify missing provenance, controls, and handoffs before any broader evaluation.

Evaluation checklist

Make the trial answer a decision

A useful evaluation produces observable answers about comprehension, evidence handling, and oversight. It should also reveal when the narrower product stops being useful.

Can a reviewer reconstruct the input?

Confirm the gene, consequence, population-frequency values, model input, and the source of every submitted field. Record any evidence the workflow cannot represent.

Can a reviewer explain the result?

Ask the evaluator to describe the output, confidence, and feature contributions without product assistance. A visible chart is not useful if the reasoning is still misunderstood.

Where does qualified judgment enter?

Identify every point where literature, database conflicts, phenotype, segregation, functional evidence, transcript choice, or a formal classification framework must be reviewed outside the model.

Does the report preserve the boundary?

Check that the exported artifact contains the inputs, output, explanation, and research-use warning without implying a diagnosis or a complete evidence record.

What would stop adoption?

Name the missing genes, variant types, integrations, audit requirements, security controls, service levels, or validation evidence that would require a broader platform.

445

variants in the repository-recorded internal holdout

97.1%

rounded accuracy in that non-clinical evaluation

4 genes

in the current cardiovascular model scope

These figures describe CardioGen AI's repository-recorded internal holdout only. They are not independent validation, comparative performance evidence, or clinical validation. Review the evidence context →

Prepare the evidence review

Understand the variant before testing the model.

Use the sourced guides to review what a variant is, how LDLR fits the FH pathway, and where population and computational evidence belong. The product result should sit inside that evidence process, not replace it.

Learn how variants are described →Review the LDLR gene guide →

Need the broader market view?

Compare VarSome Clinical and Franklin by workflow.

Open the neutral buyer guide →

Official sources used

Evaluation questions

Know the boundary before the trial

Answers reflect public documentation and CardioGen AI's current production scope.

Is CardioGen AI a free VarSome alternative?

CardioGen AI is currently available for workflow evaluation, but it is not a like-for-like replacement for VarSome Community or VarSome Clinical. If you only need a public record, start with the original source, such as ClinVar. Evaluate CardioGen AI when you need its guided four-gene cardiovascular workflow.

What makes CardioGen AI an alternative to VarSome?

The overlap is variant evidence review: both can help a team inspect variant information and a classification output. CardioGen AI is intentionally narrower, with a four-gene cardiovascular model, visible feature contributions, batch triage, and a guided research-use workflow.

When is VarSome Clinical the better fit?

VarSome Clinical is the better product to evaluate when you need a documented clinical NGS pipeline, broad gene and variant coverage, FASTQ or VCF processing, germline or somatic workflows, configurable classifications, organization knowledge, production integrations, or its current medical-device scope.

How is CardioGen AI different from ClinVar?

ClinVar is a public archive of submitted reports about variants and their relationships to health. CardioGen AI is a workflow-evaluation product that accepts evidence inputs and returns a model-assisted result for four supported genes. Neither removes the need to inspect provenance, conflicts, and qualified clinical judgment.

What inputs does CardioGen AI support today?

The current workspace supports guided single-variant entry and de-identified batch review from CSV, VCF, or text lists for its supported genes. The single-review model is limited to the current input fields and supported consequences; it does not call variants from raw FASTQ data.

Can CardioGen AI output be used for diagnosis?

No. The current product is for research and workflow evaluation. Its model classification, evidence view, and report require independent evidence review and qualified clinical judgment.

Evaluate the workflow

See the narrow path in practice.

Test one supported four-gene workflow without widening the claim.

Request a focused demo